CA2181241C - Procede pour solubiliser des agents pharmaceutiques difficilement solubles - Google Patents

Procede pour solubiliser des agents pharmaceutiques difficilement solubles Download PDF

Info

Publication number
CA2181241C
CA2181241C CA002181241A CA2181241A CA2181241C CA 2181241 C CA2181241 C CA 2181241C CA 002181241 A CA002181241 A CA 002181241A CA 2181241 A CA2181241 A CA 2181241A CA 2181241 C CA2181241 C CA 2181241C
Authority
CA
Canada
Prior art keywords
process according
peg
weight
polyethylene glycol
difficultly soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002181241A
Other languages
English (en)
Other versions
CA2181241A1 (fr
Inventor
Dadi Jamshed Dhabhar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of CA2181241A1 publication Critical patent/CA2181241A1/fr
Application granted granted Critical
Publication of CA2181241C publication Critical patent/CA2181241C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention se rapporte à un procédé pour améliorer la solubilité d'agents pharmaceutiques difficilement solubles dans un mélange de polyéthylèneglycol et de propylèneglycol, en utilisant une polyvinylpyrrolidone ayant un poids moléculaire moyen en viscosité spécifique compris entre 5000 et environ 25000.
CA002181241A 1994-01-24 1995-01-24 Procede pour solubiliser des agents pharmaceutiques difficilement solubles Expired - Fee Related CA2181241C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
US185,576 1994-01-24
PCT/US1995/001018 WO1995019759A1 (fr) 1994-01-24 1995-01-24 Procede pour solubiliser des agents pharmaceutiques difficilement solubles

Publications (2)

Publication Number Publication Date
CA2181241A1 CA2181241A1 (fr) 1995-07-27
CA2181241C true CA2181241C (fr) 2000-04-25

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002181241A Expired - Fee Related CA2181241C (fr) 1994-01-24 1995-01-24 Procede pour solubiliser des agents pharmaceutiques difficilement solubles

Country Status (14)

Country Link
EP (1) EP0741560A1 (fr)
JP (1) JPH09508128A (fr)
CN (1) CN1138827A (fr)
AU (1) AU706890B2 (fr)
BR (1) BR9506564A (fr)
CA (1) CA2181241C (fr)
CZ (1) CZ210496A3 (fr)
FI (1) FI962948A (fr)
MX (1) MX9602955A (fr)
NO (1) NO963052L (fr)
NZ (1) NZ279443A (fr)
PL (1) PL315635A1 (fr)
SK (1) SK96196A3 (fr)
WO (1) WO1995019759A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
WO1998058637A1 (fr) * 1996-06-20 1998-12-30 Mcneil-Ppc Analgesique a base d'acetaminophene et de diphenhydramine
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
JP2002509103A (ja) 1998-01-20 2002-03-26 アプライド・アナリティカル・インダストリーズ，インコーポレイテッド 経口液体組成物
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (fr) * 1999-07-29 2003-05-09 So Ge Val Sa Composition antipyretique concentree et stabilisee a usage veterinaire destine a etre incorporee a l'alimentation des animaux ainsi que procede d'incorporation de cette composition a l'eau de boisson d'animaux
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (de) * 2000-03-07 2001-09-13 Bayer Ag Acetylsalicylsäure-Lösungen
KR20020069387A (ko) * 2001-02-26 2002-09-04 진양제약주식회사 호박산독실아민 조성물 및 이 조성물을 함유한 연질캅셀제제
JP2004538309A (ja) * 2001-07-31 2004-12-24 ワイエス 不快な味覚をマスキングするためのスクラロース調合物
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (zh) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 一种难溶性药物微丸的制备方法及包含该微丸的制剂
US8333989B2 (en) * 2005-10-26 2012-12-18 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
DE102005053066A1 (de) 2005-11-04 2007-05-10 Basf Ag Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen
WO2007065846A2 (fr) * 2005-12-09 2007-06-14 Basf Se Utilisation de copolymeres blocs de lactame polyvinylique et d'oxyde de polyalkylene comme solubilisants dans des composes peu solubles dans l'eau
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (ja) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd ソフトカプセル
CA2690490C (fr) * 2010-01-19 2012-06-26 Accucaps Industries Limited Formulations pharmaceutiques de loratadine pour encapsulation et combinaisons associees
CA2690488C (fr) * 2010-01-19 2013-06-11 Accucaps Industries Limited Formulations pharmaceutiques de naproxen pour encapsulation molle et combinaisons associees
HUE031208T2 (hu) 2010-01-28 2017-07-28 Eagle Pharmaceuticals Inc Bendamusztin kiszerelései
RS65177B1 (sr) 2012-03-20 2024-03-29 Eagle Pharmaceuticals Inc Formulacije bendamustina
RS64137B1 (sr) 2012-03-20 2023-05-31 Eagle Pharmaceuticals Inc Tečne kompozicije bendamustina za upotrebu u postupku lečenja stanja koja reaguju na bendamustin kod pacijenata kojima su potrebne smanjene zapremine za primenu
CA2898408C (fr) 2013-02-28 2018-01-02 Pfizer Inc. Stabilite amelioree de compositions liquides nouvelles
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (zh) 2015-06-29 2017-06-11 永信藥品工業股份有限公司 一種製作難溶藥物固體劑型的方法
EP3364955B1 (fr) 2015-10-09 2022-04-20 RB Health (US) LLC Formulation pharmaceutique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
CZ210496A3 (en) 1996-12-11
JPH09508128A (ja) 1997-08-19
FI962948A0 (fi) 1996-07-23
FI962948A (fi) 1996-07-23
BR9506564A (pt) 1997-09-02
NO963052D0 (no) 1996-07-22
AU1607595A (en) 1995-08-08
NO963052L (no) 1996-09-24
EP0741560A1 (fr) 1996-11-13
CA2181241A1 (fr) 1995-07-27
WO1995019759A1 (fr) 1995-07-27
CN1138827A (zh) 1996-12-25
AU706890B2 (en) 1999-07-01
PL315635A1 (en) 1996-11-25
SK96196A3 (en) 1997-03-05
NZ279443A (en) 1998-04-27
MX9602955A (es) 1997-06-28

Similar Documents

Publication Publication Date Title
CA2181241C (fr) Procede pour solubiliser des agents pharmaceutiques difficilement solubles
US5484606A (en) Process for reducing the precipitation of difficulty soluble pharmaceutical actives
US5141961A (en) Process for solubilizing difficulty soluble pharmaceutical actives
CA2184365C (fr) Compositions de solution d'acetaminophene concentre
US5431916A (en) Pharmaceutical compositions and process of manufacture thereof
CA2214399C (fr) Capsule souple en gelatine avec une enveloppe comportant un derive de xanthine
US5505961A (en) Gelatin capsules containing a highly concentrated acetaminophen solution
JP5975884B2 (ja) ソフトゲルカプセル化のためのナプロキセンの医薬処方およびその組合せ
KR20190136139A (ko) 증가된 안정성의 신규한 액체 조성물
WO2002015900A1 (fr) Solutions d'ibuprofene destinees a etre mises en gelules et preparations en gelules
HUT74909A (en) Process for solubilizing difficultly soluble pharmaceutical actives
JP2006089415A (ja) カフェイン含有カプセル製剤
MXPA97007393A (en) Soft gelatine capsule with a gelatin cover comprising xant derivative
JP2006062999A (ja) カフェイン含有カプセル製剤

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed